The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Diabinese     1-(4-chlorophenyl)sulfonyl-3- propyl-urea

Synonyms: Glucamide, Insogen, Meldian, Clorpropamid, chlorpropamide, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of chlorpropamide

 

Psychiatry related information on chlorpropamide

 

High impact information on chlorpropamide

 

Chemical compound and disease context of chlorpropamide

 

Biological context of chlorpropamide

 

Anatomical context of chlorpropamide

 

Associations of chlorpropamide with other chemical compounds

 

Gene context of chlorpropamide

 

Analytical, diagnostic and therapeutic context of chlorpropamide

References

  1. Chlorpropamide-induced hypoglycemia. A dramatic presentation of celiac disease. Rosenbaum, L.H., Rosenbaum, H. JAMA (1982) [Pubmed]
  2. Chlorpropamide-induced granulomas. A probable hypersensitivity reaction in liver and bone marrow. Rigberg, L.A., Robinson, M.J., Espiritu, C.R. JAMA (1976) [Pubmed]
  3. Chlorpropamide-induced agranulocytosis. Tucker, S.C., Lynch, J.P., Ansell, B.F. JAMA (1977) [Pubmed]
  4. Distinguishing features of idiopathic flushing and carcinoid syndrome. Aldrich, L.B., Moattari, A.R., Vinik, A.I. Arch. Intern. Med. (1988) [Pubmed]
  5. Rates of hypoglycemia in users of sulfonylureas. van Staa, T., Abenhaim, L., Monette, J. Journal of clinical epidemiology. (1997) [Pubmed]
  6. Chlorpropamide action on renal concentrating mechanism in rats with hypothalamic diabetes insipidus. Kusano, E., Braun-Werness, J.L., Vick, D.J., Keller, M.J., Dousa, T.P. J. Clin. Invest. (1983) [Pubmed]
  7. A case of chronic liver disease due to tolazamide. Nakao, N.L., Gelb, A.M., Stenger, R.J., Siegel, J.H. Gastroenterology (1985) [Pubmed]
  8. Facial skin temperature and the chlorpropamide/alcohol flush in diabetics. Radder, J.K., Box, M.C., Lemkes, H.H. Lancet (1980) [Pubmed]
  9. Blockade of chlorpropamide alcohol flush by aspirin. Strakosch, C.R., Jefferys, D.B., Keen, H. Lancet (1980) [Pubmed]
  10. Chlorpropamide alcohol flushing and diabetic retinopathy. Leslie, R.D., Barnett, A.H., Pyke, D.A. Lancet (1979) [Pubmed]
  11. Once-daily use of glyburide. Ginier, P., Madan, S., Fajardo, F., Levin, S.R. Am. J. Med. (1985) [Pubmed]
  12. Clinical resistance to vasopressin. Detection of antibody by hemagglutination. Soler, N.G., Myers, W.L., Sode, J., Wortsman, J. Arch. Intern. Med. (1979) [Pubmed]
  13. The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal. Paisey, R., Elkeles, R.S., Hambley, J., Magill, P. Diabetologia (1978) [Pubmed]
  14. Water metabolism in diabetes mellitus. Davis, F.B., Davis, P.J. Am. J. Med. (1981) [Pubmed]
  15. Improved control of non-insulin-dependent diabetes mellitus by combined halofenate and chlorpropamide therapy. Kohl, E.A., Magner, J.A., Persellin, S.T., Vaughan, G.M., Kudzma, D.J., Friedberg, S.J. Diabetes Care (1984) [Pubmed]
  16. Chlorpropamide raises fructose-2,6-bisphosphate concentration and inhibits gluconeogenesis in isolated rat hepatocytes. Monge, L., Mojena, M., Ortega, J.L., Samper, B., Cabello, M.A., Feliu, J.E. Diabetes (1986) [Pubmed]
  17. Association of aldehyde dehydrogenase with inheritance of NIDDM. Suzuki, Y., Muramatsu, T., Taniyama, M., Atsumi, Y., Kawaguchi, R., Higuchi, S., Hosokawa, K., Asahina, T., Murata, C., Matsuoka, K. Diabetologia (1996) [Pubmed]
  18. Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone. Sönksen, P.H., Lowy, C., Perkins, J.R., West, T.E. Diabetologia (1981) [Pubmed]
  19. Roles of chlorpropamide, alcohol and acetaldehyde in determining the chlorpropamide-alcohol flush. Groop, L., Eriksson, C.J., Huupponen, R., Ylikahri, R., Pelkonen, R. Diabetologia (1984) [Pubmed]
  20. Sulfonylureas do not affect insulin binding or glycemic control in insulin-dependent diabetics. Grunberger, G., Ryan, J., Gorden, P. Diabetes (1982) [Pubmed]
  21. Hepatic effects of chlorpropamide: inhibition of glucagon-stimulated gluconeogenesis in perfused livers of fasted rats. Blumenthal, S.A., Whitmer, K.R. Diabetes (1979) [Pubmed]
  22. Association of hyperinsulinemia with chlorpropamide toxicity. Klonoff, D.C. Am. J. Med. (1988) [Pubmed]
  23. The significance of the cerebrospinal fluid examination in the management of chlorpropamide-induced hypoglycemia. Kaplinsky, N., Frankl, O. Diabetes Care (1980) [Pubmed]
  24. Increase of plasma acetaldehyde. An objective indicator of the chlorpropamide alcohol flush. Jerntorp, P., Ohlin, H., Bergström, B., Almér, L.O. Diabetes (1981) [Pubmed]
  25. Sulphonylureas in vitro do not alter insulin binding or insulin effect on amino acid transport in rat hepatocytes. Dolais-Kitabgi, J., Alengrin, F., Freychet, P. Diabetologia (1983) [Pubmed]
  26. Efficacy of indapamide in central diabetes insipidus. Tetiker, T., Sert, M., Koçak, M. Arch. Intern. Med. (1999) [Pubmed]
  27. Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism. Shon, J.H., Yoon, Y.R., Kim, M.J., Kim, K.A., Lim, Y.C., Liu, K.H., Shin, D.H., Lee, C.H., Cha, I.J., Shin, J.G. British journal of clinical pharmacology. (2005) [Pubmed]
  28. Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism. Coulson, R., Moses, A.M. J. Pharmacol. Exp. Ther. (1975) [Pubmed]
  29. Water retention after oral chlorpropamide is associated with an increase in renal papillary arginine vasopressin receptors. Hensen, J., Haenelt, M., Gross, P. Eur. J. Endocrinol. (1995) [Pubmed]
  30. Reversible mild diabetes in children after treatment with chlorpropamide. Mutch, W.J., Stowers, J.M. Lancet (1980) [Pubmed]
  31. Potentiation of the hepatic action of insulin by chlorpropamide. Blumenthal, S.A. Diabetes (1977) [Pubmed]
  32. Islet changes induced by hyperglycemia in rats. Effect of insulin or chlorpropamide therapy. Clark, A., Bown, E., King, T., Vanhegan, R.I., Turner, R.C. Diabetes (1982) [Pubmed]
  33. Medication compliance in non-insulin-dependent diabetes: a randomized comparison of chlorpropamide and insulin. Diehl, A.K., Sugarek, N.J., Bauer, R.L. Diabetes Care (1985) [Pubmed]
 
WikiGenes - Universities